DNA immunization confers protection against murine cytomegalovirus infection.
about
DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in miceSystemic priming-boosting immunization with a trivalent plasmid DNA and inactivated murine cytomegalovirus (MCMV) vaccine provides long-term protection against viral replication following systemic or mucosal MCMV challengeIn vivo replication, latency, and immunogenicity of murine cytomegalovirus mutants with deletions in the M83 and M84 genes, the putative homologs of human cytomegalovirus pp65 (UL83).Highly protective in vivo function of cytomegalovirus IE1 epitope-specific memory CD8 T cells purified by T-cell receptor-based cell sortingMucosal and parenteral vaccination against acute and latent murine cytomegalovirus (MCMV) infection by using an attenuated MCMV mutant.The putative natural killer decoy early gene m04 (gp34) of murine cytomegalovirus encodes an antigenic peptide recognized by protective antiviral CD8 T cells.Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65)Comparison of multiple DNA vaccines for protection against cytomegalovirus infection in BALB/c mice.Experimental preemptive immunotherapy of murine cytomegalovirus disease with CD8 T-cell lines specific for ppM83 and pM84, the two homologs of human cytomegalovirus tegument protein ppUL83 (pp65).Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant.Two antigenic peptides from genes m123 and m164 of murine cytomegalovirus quantitatively dominate CD8 T-cell memory in the H-2d haplotype.Development of a vaccine against murine cytomegalovirus (MCMV), consisting of plasmid DNA and formalin-inactivated MCMV, that provides long-term, complete protection against viral replicationStrong CD8 T-cell responses following coimmunization with plasmids expressing the dominant pp89 and subdominant M84 antigens of murine cytomegalovirus correlate with long-term protection against subsequent viral challengeDNA immunization using highly conserved murine cytomegalovirus genes encoding homologs of human cytomegalovirus UL54 (DNA polymerase) and UL105 (helicase) elicits strong CD8 T-cell responses and is protective against systemic challenge.Cellular and humoral immune responses to alphavirus replicon vaccines expressing cytomegalovirus pp65, IE1, and gB proteins.Targeted deletion of regions rich in immune-evasive genes from the cytomegalovirus genome as a novel vaccine strategy.Preliminary evidence that the novel host-derived immunostimulant EP67 can act as a mucosal adjuvant.Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania majorInterferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels.Subdominant CD8 T-cell epitopes account for protection against cytomegalovirus independent of immunodomination.25-Hydroxycholesterol activates the integrated stress response to reprogram transcription and translation in macrophages.Multiple epitopes in the murine cytomegalovirus early gene product M84 are efficiently presented in infected primary macrophages and contribute to strong CD8+-T-lymphocyte responses and protection following DNA immunization.Vaccination of mice with bacteria carrying a cloned herpesvirus genome reconstituted in vivo.Human cytomegalovirus vaccine development: Immune responses to look into vaccine strategy.
P2860
Q27469515-49EF26B7-064B-4B56-B08A-88F0140A3853Q33551402-B72F159C-6774-4EF5-B59B-D628D8B5FCF7Q33650230-E9AF724A-D188-48CC-93F9-36A849476E44Q33755031-23A7B29E-D3BF-4C22-B8B3-916573420907Q33782029-6A3D8979-89CE-40DF-8AF4-B89764F29CFCQ33797749-96978DE7-DA83-4632-98DE-717E24AD088CQ33802461-A5A25DFA-653B-4F6B-924B-6B4C654CB227Q33813837-4246FB06-28E7-4921-9CAF-CDD4DCE783E5Q33843590-DC5736E9-936E-4B74-9DEB-8334411B9340Q34102747-E1726BF9-2B4C-4640-8C04-60EB5F967258Q34327234-BF255472-1922-4D11-ADC3-1BEC4C9AC65AQ34338715-BADED925-8561-4931-84C1-5534E6A2188FQ34970937-901EBE09-8919-4E34-B29C-A3A8A265A468Q35914513-32FE2794-92FD-4675-BFE3-8BA31AAFDE23Q35946943-2D79602D-C00E-4556-B30E-AA8ED91BA230Q36315171-66335B9A-EFB4-4429-8E37-CB1AB2395FFEQ36315607-3BE4B272-8316-43DB-AD92-FE1CBB10F180Q36380692-80BD7989-E16F-4BDF-90BB-AF142BF800DDQ36401507-14BBAE27-0760-46FC-A735-881BE109F660Q36673260-BF5CFCDE-F4BE-4A62-8D5F-1C21A4DA0B2EQ37388798-4AA8E742-F38D-4600-B455-5A3034107605Q37567900-C7793700-B8A6-4909-B711-5396A2C85E21Q39789433-47BBC48C-E08B-466D-A66A-437A14FFA1C6Q47605886-33D681E7-642D-46A8-BE33-33D840190463
P2860
DNA immunization confers protection against murine cytomegalovirus infection.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
DNA immunization confers protection against murine cytomegalovirus infection.
@ast
DNA immunization confers protection against murine cytomegalovirus infection.
@en
type
label
DNA immunization confers protection against murine cytomegalovirus infection.
@ast
DNA immunization confers protection against murine cytomegalovirus infection.
@en
prefLabel
DNA immunization confers protection against murine cytomegalovirus infection.
@ast
DNA immunization confers protection against murine cytomegalovirus infection.
@en
P2093
P2860
P1433
P1476
DNA immunization confers protection against murine cytomegalovirus infection.
@en
P2093
C S Morello
D H Spector
J C González Armas
L D Cranmer
P2860
P304
P407
P577
1996-11-01T00:00:00Z